Narrow search
Showing 1 - 10 of 73
Cover Image
Das Wachstum in der Medizin - Mythen und Fakten - Zur aktuellen gesundheitspolitischen Fragestellung in Deutschland
Schwartz, Friedrich Wilhelm; Busse, Reinhard - In: Arbeit und Sozialpolitik 48 (1994) 9-10, pp. 10-18
Persistent link: https://www.econbiz.de/10006005115
Cover Image
Zur Umsetzung ergebnisorientierter Vergütungselemente in der ambulanten Versorgung
Krauth, Christian; Schwartz, Friedrich Wilhelm; … - In: Arbeit und Sozialpolitik 52 (1998) 11-12, pp. 10-22
Persistent link: https://www.econbiz.de/10005972108
Cover Image
Europäisches Netzwerk soll "informierte Entscheidungen" in der Gesundheitspolitik ermöglichen
Perleth, Matthias; Busse, Reinhard; Schwartz, Friedrich … - In: Arbeit und Sozialpolitik 50 (1996) 7-8, pp. 57-58
Persistent link: https://www.econbiz.de/10005991771
Cover Image
Eine neue Dimension in der Vergütungsdiskussion
Schwartz, Friedrich Wilhelm; Haase, Ingo; Busse, Reinhard - In: Arbeit und Sozialpolitik 49 (1995) 5-6, pp. 29-35
Persistent link: https://www.econbiz.de/10005996158
Cover Image
Regulation of health-related technologies in Germany
Perleth, Matthias; Busse, Reinhard; Schwartz, Friedrich … - In: Health Policy 46 (1999) 2, pp. 105-126
Persistent link: https://www.econbiz.de/10005520118
Cover Image
DO DIAGNOSIS‐RELATED GROUPS EXPLAIN VARIATIONS IN HOSPITAL COSTS AND LENGTH OF STAY? – ANALYSES FROM THE EURODRG PROJECT FOR 10 EPISODES OF CARE ACROSS 10 EuroPEAN COUNTRIES
Busse, Reinhard; Geissler, Alexander; Mason, Anne; Or, … - In: Health Economics 21 (2012) 08, pp. 1-5
Persistent link: https://www.econbiz.de/10011005391
Cover Image
Leitlinien in der medizinischen Rehabilitation
Helou, Antonius; Korsukéwitz, Christiane; Schwartz, … - In: Die Angestellten-Versicherung : Zeitschrift der … 46 (1999) 12, pp. 563-568
Persistent link: https://www.econbiz.de/10006910733
Cover Image
Analysis of endpoints used in marketing authorisations versus value assessments of oncology medicines in Germany
Ruof, Jörg; Knoerzer, Dietrich; Dünne, Anja-Alexandra; … - In: Health Policy 118 (2014) 2, pp. 242-254
In Germany, a mandatory early benefit assessment (EBA) by the Federal Joint Committee (G-BA) is required for reimbursement of new marketing-authorised medicines. Additional benefit is based on patient-relevant endpoints in mortality, morbidity and health-related quality of life (HRQoL). We aimed...
Persistent link: https://www.econbiz.de/10011116913
Cover Image
Possibilities for intervention in adolescents' and young adults' depression from a public health perspective
Bramesfeld, Anke; Platt, Lisa; Schwartz, Friedrich Wilhelm - In: Health Policy 79 (2006) 2-3, pp. 121-131
Persistent link: https://www.econbiz.de/10005516792
Cover Image
German physicians "on strike"--Shedding light on the roots of physician dissatisfaction
Janus, Katharina; Amelung, Volker Eric; Gaitanides, Michael - In: Health Policy 82 (2007) 3, pp. 357-365
Persistent link: https://www.econbiz.de/10005520231